Molecular interaction studies of Deguelin and its derivatives with Cyclin D1 and Cyclin E in cancer cell signaling pathway: The computational approach

• Published in: Scientific reports Vol. 9; no. 1; p. 1778
• Main Authors: Lokhande, Kiran Bharat, Nagar, Shuchi, Swamy, K. Venkateswara
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 11.02.2019; Nature Publishing Group
• Subjects: 119/118; 631/67/1059/153; 692/699/67; Apoptosis; Cancer; Cell cycle; Computer applications; Conformation; Cyclin D1; Cyclin E; Humanities and Social Sciences; Hydrogen bonding; Ligands; Molecular dynamics; multidisciplinary; Science; Science (multidisciplinary); Signal transduction
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-018-38332-6

Deguelin is a major active ingredient and principal component in several plants and it is a potential molecule to target proteins of cancer cell signaling pathway. As a complex natural extract, deguelin interacts with various molecular targets to exert its anti-tumor properties at nanomolar level. It induces cell apoptosis by blocking anti-apoptotic pathways, while inhibiting tumor cell multiplication and malignant transformation through p27-cyclin-E-pRb-E2F1- cell cycle control and HIF-1alphaVEGF antiangiogenic pathways. In silico studies of deguelin and its derivatives is performed to explore interactions with Cyclin D1 and Cyclin E to understand the molecular insights of derivatives with the receptors. Deguelin and its derivatives are minimized by Avogadro to achieve stable conformation. All docking simulation are performed with AutoDockVina and virtual screening of docked ligands are carried out based on binding energy and number of hydrogen bonds. Molecular dynamics (MD) and Simulation of Cyclin D1 and Cyclin E1 is performed for 100 ns and stable conformation is obtained at 78 ns and 19 ns respectively. Ligands thus obtained from docking studies may be probable target to inhibit cancer cell signaling pathways.